Prognostic markers in lentigo maligna patients treated with imiquimod cream: A long-term follow-up study
- 1 January 2016
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 74 (1) , 81-87.e1
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A quantitative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearanceJournal of the American Academy of Dermatology, 2015
- Distinctive Features of Melanoma and Its Management in Elderly PatientsJAMA Dermatology, 2013
- Lentigo Maligna: Review of Salient Characteristics and ManagementAmerican Journal of Clinical Dermatology, 2013
- Radiotherapy for lentigo maligna: a literature review and recommendations for treatmentBritish Journal of Dermatology, 2013
- Grenz ray treatment of lentigo maligna and early lentigo maligna melanomaJournal of the American Academy of Dermatology, 2012
- Melanoma In Situ Treated Successfully Using Imiquimod After Nonclearance with Surgery: Review of the LiteratureDermatologic Surgery, 2012
- Guidelines of care for the management of primary cutaneous melanomaJournal of the American Academy of Dermatology, 2011
- A pilot study of treatment of lentigo maligna with 5% imiquimod creamBritish Journal of Dermatology, 2004
- A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-raysBritish Journal of Dermatology, 2002
- Imiquimod: a novel treatment for lentigo malignaBritish Journal of Dermatology, 2000